Literature DB >> 18687500

Antibiotic-eluting medical devices for various applications.

Meital Zilberman1, Jonathan J Elsner.   

Abstract

Infection is defined as a homeostatic imbalance between the host tissue and the presence of microorganisms. It is associated with a large variety of wound occurrences ranging from traumatic skin tears and burns to chronic ulcers and complications following surgery and device implantations. If the wound setting manages to overcome the microorganism invasion by a sufficient immune response then the wound should heal. If not, the formation of an infection can seriously limit the wound healing process. Evidence of increasing bacterial resistance is on the rise, and complications associated with infections are therefore expected to increase. The main goal in treating various types of wound infections is to decrease the bacterial load in the wound to a level that enables wound healing processes to take place. Conventional systemic delivery of antibiotics entails poor penetration into ischemic and necrotic tissue and can cause systemic toxicity with associated renal and liver complications, which result in a need for hospitalization for monitoring. Alternative local delivery of antibiotics by either topical administration or by a delivery device may enable the maintenance of a high local antibiotic concentration for an extended duration of release without exceeding systemic toxicity. The present review describes approaches for local prevention of bacterial infections based on antibiotic-eluting medical devices. These devices include bone cements, fillers and coatings for orthopedic applications, wound dressings based on synthetic and natural polymers, intravascular devices, vascular grafts and periodontal devices. Part of the review is dedicated to our novel composite drug-eluting fibers and structured drug-eluting films, which are designed to be used as basic elements of various devices. In this review emphasis is placed on processing techniques, microstructure, drug release profiles, biocompatibility and other relevant aspects necessary for advancing the therapeutic field of antibiotic-eluting devices.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18687500     DOI: 10.1016/j.jconrel.2008.05.020

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  103 in total

Review 1.  Calcium Phosphate Bioceramics: A Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications.

Authors:  Noam Eliaz; Noah Metoki
Journal:  Materials (Basel)       Date:  2017-03-24       Impact factor: 3.623

2.  Bio-inspired porous SiC ceramics loaded with vancomycin for preventing MRSA infections.

Authors:  P Díaz-Rodríguez; M Landin; A Rey-Rico; J Couceiro; T Coenye; P González; J Serra; M López-Álvarez; B León
Journal:  J Mater Sci Mater Med       Date:  2010-12-05       Impact factor: 3.896

3.  Tunable staged release of therapeutics from layer-by-layer coatings with clay interlayer barrier.

Authors:  Jouha Min; Richard D Braatz; Paula T Hammond
Journal:  Biomaterials       Date:  2013-12-31       Impact factor: 12.479

Review 4.  Tissue-engineered skin substitutes: an overview.

Authors:  Enrico Catalano; Andrea Cochis; Elena Varoni; Lia Rimondini; Barbara Azzimonti
Journal:  J Artif Organs       Date:  2013-10-05       Impact factor: 1.731

5.  Chitosan sponges to locally deliver amikacin and vancomycin: a pilot in vitro evaluation.

Authors:  Scott P Noel; Harry S Courtney; Joel D Bumgardner; Warren O Haggard
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

6.  Ciprofloxacin-lidocaine-based hydrogel: development, characterization, and in vivo evaluation in a second-degree burn model.

Authors:  María Florencia Sanchez; Susana Andrea Breda; Elio Andrés Soria; Luis Ignacio Tártara; Rubén Hilario Manzo; María Eugenia Olivera
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

Review 7.  Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds.

Authors:  Viviana Mouriño; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2009-10-28       Impact factor: 4.118

8.  Infection-responsive drug delivery from urinary biomaterials controlled by a novel kinetic and thermodynamic approach.

Authors:  Nicola J Irwin; Colin P McCoy; David S Jones; Sean P Gorman
Journal:  Pharm Res       Date:  2012-11-15       Impact factor: 4.200

9.  Mitigation of peri-implantitis by rational design of bifunctional peptides with antimicrobial properties.

Authors:  E Cate Wisdom; Yan Zhou; Casey Chen; Candan Tamerler; Malcolm L Snead
Journal:  ACS Biomater Sci Eng       Date:  2019-09-24

10.  Vancomycin-bearing synthetic bone graft delivers rhBMP-2 and promotes healing of critical rat femoral segmental defects.

Authors:  Jordan D Skelly; Jeffrey Lange; Tera M Filion; Xinning Li; David C Ayers; Jie Song
Journal:  Clin Orthop Relat Res       Date:  2014-08-07       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.